Skip to main content
Top
Published in:

Open Access 20-12-2024 | Kawasaki Disease | Case report

Atypical Kawasaki disease with giant coronary artery aneurysms in a 2-month-old boy: a case report

Authors: Najmeh Navidi, Babak Najibi, Negar Dinarvand, Amirmohammad Zamani, Mohammad Reza Fathi

Published in: Journal of Medical Case Reports | Issue 1/2024

Login to get access

Abstract

Background

Kawasaki disease is an acute inflammatory disorder primarily affecting medium-sized blood vessels, especially in infants and young children under 5 years old, characterized by inflammation of the arterial walls, including coronary arteries. While predominantly affecting young children, rarely Kawasaki disease is seen in adults. Reporting this case is crucial due to the patient’s very young age and the disease’s unusual presentation following vaccination, contributing to the limited literature on Kawasaki disease in very young infants.

Case presentation

A full-term, 2-month-and-10-day-old Iranian boy presented with persistent fever unresponsive to treatment, beginning 5 days after receiving the 5-in-1 vaccine. Although physical examination results were normal, his medical history included maternal hypothyroidism during pregnancy and neonatal jaundice that did not require hospitalization. Initial laboratory tests revealed bicytopenia, thrombocytosis on the complete blood count, and elevated erythrocyte sedimentation rate and C-reactive protein levels. Echocardiography identified giant coronary artery aneurysms. The patient was diagnosed with atypical Kawasaki disease and treated with intravenous immunoglobulin, methylprednisolone, infliximab, and aspirin, which resolved his fever.

Conclusions

This case emphasizes the importance of considering Kawasaki disease as a differential diagnosis in infants with persistent, treatment-resistant fever and abnormal complete blood count findings. Early diagnosis and timely intervention are essential to prevent severe complications, such as coronary artery aneurysms and possible mortality. It underscores the need for heightened awareness and vigilance among healthcare providers in similar clinical scenarios.
Literature
1.
go back to reference Kontopoulou T, Kontopoulos DG, Vaidakis E, Mousoulis GP. Adult Kawasaki disease in a European patient: a case report and review of the literature. J Med Case Rep. 2015;9(1):1–7.CrossRef Kontopoulou T, Kontopoulos DG, Vaidakis E, Mousoulis GP. Adult Kawasaki disease in a European patient: a case report and review of the literature. J Med Case Rep. 2015;9(1):1–7.CrossRef
2.
go back to reference Singh S, Vignesh P, Burgner D. The epidemiology of Kawasaki disease: a global update. Archives of disease in childhood. 2015:archdischild-2014–307536. Singh S, Vignesh P, Burgner D. The epidemiology of Kawasaki disease: a global update. Archives of disease in childhood. 2015:archdischild-2014–307536.
4.
go back to reference Bell DM, Morens DM, Holman RC, Hurwitz ES, Hunter MK. Kawasaki syndrome in the United States: 1976 to 1980. Am J Dis Child. 1983;137(3):211–4.CrossRefPubMed Bell DM, Morens DM, Holman RC, Hurwitz ES, Hunter MK. Kawasaki syndrome in the United States: 1976 to 1980. Am J Dis Child. 1983;137(3):211–4.CrossRefPubMed
5.
go back to reference Holman RC, Christensen KY, Belay ED, Steiner CA, Effler PV, Miyamura J, et al. Racial/ethnic differences in the incidence of Kawasaki syndrome among children in Hawai ‘i. Hawaii Med J. 2010;69(8):194.PubMedPubMedCentral Holman RC, Christensen KY, Belay ED, Steiner CA, Effler PV, Miyamura J, et al. Racial/ethnic differences in the incidence of Kawasaki syndrome among children in Hawai ‘i. Hawaii Med J. 2010;69(8):194.PubMedPubMedCentral
6.
go back to reference Abrams JY, Weintraub ES, Baggs JM, McCarthy NL, Schonberger LB, Lee GM, et al. Childhood vaccines and Kawasaki disease, vaccine safety datalink, 1996–2006. Vaccine. 2015;33(2):382–7.CrossRefPubMed Abrams JY, Weintraub ES, Baggs JM, McCarthy NL, Schonberger LB, Lee GM, et al. Childhood vaccines and Kawasaki disease, vaccine safety datalink, 1996–2006. Vaccine. 2015;33(2):382–7.CrossRefPubMed
7.
go back to reference Baker MA, Baer B, Kulldorff M, Zichittella L, Reindel R, DeLuccia S, et al. Kawasaki disease and 13-valent pneumococcal conjugate vaccination among young children: a self-controlled risk interval and cohort study with null results. PLoS Med. 2019;16(7): e1002844.CrossRefPubMedPubMedCentral Baker MA, Baer B, Kulldorff M, Zichittella L, Reindel R, DeLuccia S, et al. Kawasaki disease and 13-valent pneumococcal conjugate vaccination among young children: a self-controlled risk interval and cohort study with null results. PLoS Med. 2019;16(7): e1002844.CrossRefPubMedPubMedCentral
8.
go back to reference Hall GC, Tulloh RM, Tulloh LE. The incidence of Kawasaki disease after vaccination within the UK pre-school national immunisation programme: an observational THIN database study. Pharm Drug Saf. 2016;25(11):1331–6. Hall GC, Tulloh RM, Tulloh LE. The incidence of Kawasaki disease after vaccination within the UK pre-school national immunisation programme: an observational THIN database study. Pharm Drug Saf. 2016;25(11):1331–6.
10.
go back to reference Hangai M, Kubota Y, Kagawa J, Yashiro M, Uehara R, Nakamura Y, et al. Neonatal Kawasaki disease: case report and data from nationwide survey in Japan. Eur J Pediatr. 2014;173:1533–6.CrossRefPubMed Hangai M, Kubota Y, Kagawa J, Yashiro M, Uehara R, Nakamura Y, et al. Neonatal Kawasaki disease: case report and data from nationwide survey in Japan. Eur J Pediatr. 2014;173:1533–6.CrossRefPubMed
11.
go back to reference Hall GC, Tulloh LE, Tulloh RM. Kawasaki disease incidence in children and adolescents: an observational study in primary care. Br J Gen Pract. 2016;66(645):e271–6.CrossRefPubMedPubMedCentral Hall GC, Tulloh LE, Tulloh RM. Kawasaki disease incidence in children and adolescents: an observational study in primary care. Br J Gen Pract. 2016;66(645):e271–6.CrossRefPubMedPubMedCentral
12.
go back to reference Daniels LB, Gordon JB, Burns JC. Kawasaki disease: late cardiovascular sequelae. Curr Opin Cardiol. 2012;27(6):572–7.CrossRefPubMed Daniels LB, Gordon JB, Burns JC. Kawasaki disease: late cardiovascular sequelae. Curr Opin Cardiol. 2012;27(6):572–7.CrossRefPubMed
13.
go back to reference McCrindle BW, Li JS, Minich LL, Colan SD, Atz AM, Takahashi M, et al. Coronary artery involvement in children with Kawasaki disease: risk factors from analysis of serial normalized measurements. Circulation. 2007;116(2):174–9.CrossRefPubMed McCrindle BW, Li JS, Minich LL, Colan SD, Atz AM, Takahashi M, et al. Coronary artery involvement in children with Kawasaki disease: risk factors from analysis of serial normalized measurements. Circulation. 2007;116(2):174–9.CrossRefPubMed
14.
go back to reference McCrindle BW, Rowley AH, Newburger JW, Burns JC, Bolger AF, Gewitz M, et al. Diagnosis, treatment, and long-term management of Kawasaki disease: a scientific statement for health professionals from the American Heart Association. Circulation. 2017;135(17):927–99.CrossRef McCrindle BW, Rowley AH, Newburger JW, Burns JC, Bolger AF, Gewitz M, et al. Diagnosis, treatment, and long-term management of Kawasaki disease: a scientific statement for health professionals from the American Heart Association. Circulation. 2017;135(17):927–99.CrossRef
16.
go back to reference Makino N, Nakamura Y, Yashiro M, Ae R, Tsuboi S, Aoyama Y, et al. Descriptive epidemiology of Kawasaki disease in Japan, 2011–2012: from the results of the 22nd nationwide survey. J Epidemiol. 2015;25(3):239–45.CrossRefPubMed Makino N, Nakamura Y, Yashiro M, Ae R, Tsuboi S, Aoyama Y, et al. Descriptive epidemiology of Kawasaki disease in Japan, 2011–2012: from the results of the 22nd nationwide survey. J Epidemiol. 2015;25(3):239–45.CrossRefPubMed
17.
go back to reference Bayers S, Shulman ST, Paller AS. Kawasaki disease: part I diagnosis, clinical features, and pathogenesis. J Am Acad Dermatol. 2013;69(4):501.CrossRef Bayers S, Shulman ST, Paller AS. Kawasaki disease: part I diagnosis, clinical features, and pathogenesis. J Am Acad Dermatol. 2013;69(4):501.CrossRef
18.
go back to reference Jin P, Luo Y, Liu X, Xu J, Liu C. Kawasaki disease complicated with macrophage activation syndrome: case reports and literature review. Front Pediatr. 2019;7:423.CrossRefPubMedPubMedCentral Jin P, Luo Y, Liu X, Xu J, Liu C. Kawasaki disease complicated with macrophage activation syndrome: case reports and literature review. Front Pediatr. 2019;7:423.CrossRefPubMedPubMedCentral
19.
go back to reference Lin Y, Shi L, Deng Y-j, Liu Y, Zhang H-w. Kawasaki disease shock syndrome complicated with macrophage activation syndrome in a 5-month old boy: a case report. Medicine. 2019;98(4):14203.CrossRef Lin Y, Shi L, Deng Y-j, Liu Y, Zhang H-w. Kawasaki disease shock syndrome complicated with macrophage activation syndrome in a 5-month old boy: a case report. Medicine. 2019;98(4):14203.CrossRef
20.
go back to reference García-Pavón S, Yamazaki-Nakashimada MA, Báez M, Borjas-Aguilar KL, Murata C. Kawasaki disease complicated with macrophage activation syndrome: a systematic review. J Pediatr Hematol Oncol. 2017;39(6):445–51.CrossRefPubMed García-Pavón S, Yamazaki-Nakashimada MA, Báez M, Borjas-Aguilar KL, Murata C. Kawasaki disease complicated with macrophage activation syndrome: a systematic review. J Pediatr Hematol Oncol. 2017;39(6):445–51.CrossRefPubMed
22.
go back to reference Jakob A, Whelan J, Kordecki M, Berner R, Stiller B, Arnold R, et al. Kawasaki disease in Germany. Pediatr Infect Dis J. 2016;35(2):129–34.CrossRefPubMed Jakob A, Whelan J, Kordecki M, Berner R, Stiller B, Arnold R, et al. Kawasaki disease in Germany. Pediatr Infect Dis J. 2016;35(2):129–34.CrossRefPubMed
Metadata
Title
Atypical Kawasaki disease with giant coronary artery aneurysms in a 2-month-old boy: a case report
Authors
Najmeh Navidi
Babak Najibi
Negar Dinarvand
Amirmohammad Zamani
Mohammad Reza Fathi
Publication date
20-12-2024
Publisher
BioMed Central
Published in
Journal of Medical Case Reports / Issue 1/2024
Electronic ISSN: 1752-1947
DOI
https://doi.org/10.1186/s13256-024-04987-1